MIRA INFORM REPORT

 

 

Report Date :

16.03.2007

 

IDENTIFICATION DETAILS

 

Name :

BERLIN  PHARMACEUTICAL  INDUSTRY  CO., LTD.

 

 

Registered Office :

359  New  Road,  Pomprab,  Pomprabsatrupai, Bangkok  10100, 

 

 

Country :

Thailand                                   

 

 

Financials (as on) :

31.12.2005

 

 

Date of Incorporation :

1984

 

 

Com. Reg. No.:

0105527028430

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Manufacturing  and  marketing  various  kinds  of  medical  and  pharmaceutical  products.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 


name

 

BERLIN  PHARMACEUTICAL  INDUSTRY  CO., LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           359  NEW  ROAD,  POMPRAB,  POMPRABSATRUPAI,

                                                                        BANGKOK  10100,  THAILAND                          

TELEPHONE                                         :           [66]  2225-4261-3 

FAX                                                      :           [66]  2225-4261

E-MAIL  ADDRESS                                :           -

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

 

ESTABLISHED                                     :           1984

REGISTRATION  NO.                           :           0105527028430 [Former: 2844/2527]

CAPITAL REGISTERED                         :           BHT.  10,000,000

CAPITAL PAID-UP                                :           BHT.  10,000,000

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MRS.  WANIDA  CHAINUWAT,   THAI

                                                                        MANAGING  DIRECTOR           

 

NO.  OF  STAFF                                   :           269

LINES  OF  BUSINESS                          :           MEDICAL  AND  PHARMACEUTICAL  PRODUCTS

                                                                        MANUFACTURING  AND  MARKETING 

                                                                                                                                                 

                                                                         

CORPORATE  PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  GOOD  PERFORMANCE                       

 

 

 

 

 

 

 


 

HISTORY

 

The  subject  was  established  on  August  7, 1984  as  a  private  limited  company under  the    name  BERLIN  PHARMACEUTICAL INDUSTRY CO., LTD.  by  Thai  groups,     in  order  to  manufacture and  market  medical  and  pharmaceutical  products  for domestic  and  overseas  markets.   It  currently  employs  269  staff.  

 

On  July 12, 2002,  the subject  was changed its  name to  BERLIN  PHARMA [THAILAND]  CO., LTD.  However,  it  was  re-named  to  BERLIN  PHARMACEUTICAL  INDUSTRY  CO., LTD.  again  on  September  12,  2002.

 

The  subject’s  registered  address  is  359  New  Rd., Pomprab, Pomprabsatrupai, Bangkok 10100,   and   this  is  the  subject’s  current  operation  address.  

 

 

THE  BOARD  OF  DIRECTORS

 

     Name

 

Nationality

Age

 

 

 

 

Mrs.  Sanguan  Chainuwat

 

Thai

94

Mr.  Termchai  Chainuwat

 

Thai

68

Mr. Suebchai  Chainuwat

 

Thai

64

Mrs.  Wanida  Chainuwat

 

Thai

67

Ms. Winda  Chainuwat

 

Thai

42

Mrs.  Lalana  Satesuban

 

Thai

63

Ms.  Choon  Vatanyuta

 

Thai

78

 

 

AUTHORIZED  PERSON

 

Two  of  the  above  directors  can  jointly  sign  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Mrs.  Wanida  Chainuwat  is  the  Managing  Director.

She  is  Thai  nationality  with  the  age  of  67  years  old.

 

Mrs.  Lalana  Satesuban  is  the  Export  Manager.

She  is  Thai  nationality  with  the  age  of  63 years  old.

  

Mr.  Suraphan  Uransakul  is  the  Sales  Manager.

He  is  Thai  nationality.

 

Ms.  Sasithorn  Udomchaiteerakul  is  the   Factory   Manager.

She  is  Thai  nationality.

 

 

BUSINESS  OPERATIONS

 

The  subject  is  engaged  in  manufacturing  and  marketing  various  kinds  of  medical  and  pharmaceutical  products  including  powder  tablet,  capsule,  liquid,  ointment,  cream  and  gastrology  drug  and  etc.  The products  are  produced  under  the  standard of  ISO and Foods and  Drugs  Organization.

 

PURCHASE

 

Raw  materials  are  purchased  from  suppliers  and  agents  both  local   and  overseas  countries  such  as  Germany, United States  of  America,  United Kingdom,  France,  Japan  and  Republic  of  China.

 

 

MAJOR  SUPPLIER

 

BASF  [Thai]  Ltd.          :  Thailand

 

 

SALES 

 

Most  of  its  products  are  sold  locally  by  wholesale  to dealers  and  end-users  both  government  and  private  sector  all  over  the  country.

 

 

EXPORT

 

Some  of  the  products  is  exported  to  Singapore,  India,  Laos,  Myanmar,   Vietnam,  Indonesia,  Hong Kong  and   Sri  Lanka.

 

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

 

The  subject  is  not  found   to  have  any  subsidiary  nor  affiliated  company  here  in  Thailand.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against   the  subject  for  the  past  two  years.

 

 

CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  L/C  at  sight  or  T/T  on  negotiated  term.

Exports  are  against  L/C  at  sight  or  T/T  on  negotiated  term.

 

 

BUSINESS  TRANSACTION

 

The  products  are  sold  both  by  cash  and  credit  with  the  maximum  credit  given  at  30-60  days.  There  is  no  problem  on  its  account  receivable.

 

 

BANKING

 

Kasikornbank  Public  Co., Ltd.          

  [Head  Office : 1 Kasikorn Lane,  Rajburana Rd., Rajburana,  Bangkok 10140]

 

Bangkok  Bank  Public  Co.,  Ltd.       

  [Head  Office : 333  Silom  Rd.,  Silom,  Bangrak,  Bangkok  10500]

 

Krung  Thai  Bank  Public  Co.,  Ltd.              

  [Head Office : 35 Sukhumvit  Rd.,  Klongtoeynua,  Wattana,  Bangkok  10110]

 

 

EMPLOYMENT

 

The  subject  employs  approximately  269  staff  [office  staff  and  factory  workers].

 

 

LOCATION   DETAILS

 

The  premise  is  rented  for  administrative  office at  the  heading  address.  Premise  is  located  in  commercial   area.

 

Factory & warehouse are located at 374  Romklao Rd., Klongsampraves,  Ladkrabang,  Bangkok 10520,    Tel : [66]  2360-8729.

 

Recently  the  factory  &  warehouse’s  address  has  been  changed  to  63  Moo 5, Romklao Rd., Klongsampraves,  Ladkrabang,  Bangkok 10520,  Tel:  [66] 2737-6717  Fax : [66]  2360-8729.   [Only  the  address  number  has  been  changed,  but  they  are  the  same  location.]

 

 

REMARK

 

CREDIT  OF  US$  1,500,000  SHOULD  BE  IN  ORDER.

 

 

COMMENT

 

Since the subject has  been  established in Thailand more  than  20  years,  its products have been well accepted  from  local  market and  international  markets  with  steady  growth each year.

 

The  company’s  productions  are  properly  run  by  expertise.   Though  there  is  a  decrease  in  its  net  profit  in  2005 comparing  to the  previous  year,  it  is  still  enjoying  an  outstanding  performance.  

 

The  subject  is  doing  excellent  business  and  expanding   steadily.

 

 

FINANCIAL  INFORMATION

 

The  capital  was  initially registered  at  Bht. 1,000,000  divided  into  100,000 shares  of  Bht.  10  each.

 

The  capital  was  increased  later  as  following:

 

            Bht.     5,000,000  on  October  25,  1985

            Bht.   10,000,000  on  October  31,  1989 

           

The  latest  registered  capital  was  increased  to  Bht. 10,000,000  divided  into  1,000,000  shares  of  Bht.  10   each  with  fully  paid.

 

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at  April  30.,  2006]

 

       NAME

HOLDING

%

 

 

 

Ms.  Winda  Chainuwat

Nationality: Thai

Address    : 458/1-3  Rama 1 Rd., Pathumwan, Bangkok  10330   

240,000

24.00

Mr.  Athisit  Chainuwat

Nationality: Thai

Address    : 8/2  Sukhumvit  49 Rd., Prakanong, Bangkok 10110  

190,000

19.00

Mr.  Termchai  Chainuwat

Nationality: Thai

Address    : 458/1-3  Rama  1 Rd., Pathumwan, Bangkok 10330

180,000

18.00

Ms.  Maneechay  Chainuwat

Nationality: Thai

Address    : 8/2  Sukhumvit  49 Rd., Prakanong, Bangkok 10110    

125,000

12.50

Mr. Nathachai  Chainuwat

Nationality: Thai

Address    : 8/2  Sukhumvit  49 Rd., Prakanong, Bangkok 10110     

125,000

12.50

Ms.  Sivaporn  Chainuwat

Nationality: Thai

Address    : 458/1-3  Rama  1 Rd.,  Pathumwan, Bangkok 10330       

80,000

8.00

Mr.  Ekachai  Chainuwat

Nationality: Thai  

Address    : 458/1-3  Rama  1 Rd.,  Pathumwan, Bangkok 10330

30,000

3.00

Mrs.  Wanida  Chainuwat

Nationality: Thai 

Address    : 458/1-3  Rama  1 Rd.,  Pathumwan, Bangkok 10330

10,000

1.00

Ms.  Choon  Vatanyuta

Nationality: Thai 

Address    : 1764/1  Rama 6 Rd., Rd.,  Rongmuang,

                  Pathuman,  Bangkok   

10,000

1.00

Mrs.  Lalana  Satesuban

Nationality: Thai 

Address    : 56/3  Moo 2,  Klongchan,  Bangkapi, Bangkok    

10,000

1.00

 

 

Total  Shareholders  

 

10

 

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC  

ACCOUNTANT  NO. :

 

Mr.  Kasem  Thoonkrisana No.  5643

          


 

BALANCE SHEET [BAHT]

 

The  latest  financial  figures  published  for  December  31,  2005  &  2004  were:

          

ASSETS

                                                                                                 

Current Assets

2005

2004

 

 

 

Cash   in   hand  &  at  Bank             

39,617,701.58

5,207,902.18

Short  Term  Investment

401,000.00

401,000.00

Trade  Accts.  Receivable

331,216,644.71

261,195,606.62

Short-term  Loan  to  Person  or Related Company

311,054.49

20,000.00

Inventories                                  

100,243,759.65

99,973,831.90

Other  Current  Assets                

39,639,910.27

30,664,031.67

 

 

 

Total  Current  Assets                

511,430,070.70

397,462,372.37

 

Long  Term  Loan  to  Person  or  Related 

  Company

 

 

4,238,852.88

 

 

8,259,221.51

Investment  in  Related  Company

3,343,363.44

3,343,363.44

Long  Term  Investment

1,192,900.00

1,192,900.00

Fixed Assets                              

168,099,930.53

138,959,534.11

Intangible  Assets                       

16,363,557.58

14,482,951.54

Other  Assets                            

5,318,641.47

4,368,891.65

 

Total  Assets                 

 

709,987,316.60

 

568,069,234.62


 

LIABILITIES & SHAREHOLDERS' EQUITY [BAHT]

 

 

Current Liabilities

2005

2004

 

 

 

Bank  Overdraft   from  Financial  Institution 

-

19,592,969.20

Trade  Accts.  Payable

147,961,788.18

92,593,113.73

Short  Term  Loan  from  Financial  Institution

-

15,000,000.00

Hire-Purchase  Payable

5,576,601.63

1,813,079.87

Other  Current  Liabilities             

196,755,764.87

125,986,292.05

 

 

 

Total Current Liabilities

350,294,154.68

254,985,454.85

 

Other  Long  Term  Loans

 

10,465,259.25

 

8,711,475.11

 

Total  Liabilities            

 

360,759,413.93

 

263,696,929.96

 

 

 

Shareholders' Equity

 

 

 

 

 

 Share  capital : Baht  10  par  value 

  authorized,  issued  and  fully 

  paid  share  capital   1,000,000  shares

 

 

10,000,000.00

 

 

10,000,000.00

 

 

 

Capital  Paid                      

10,000,000.00

10,000,000.00

Statutory  Reserve

1,000,000.00

1,000,000.00

Retained  Earning - Unappropriated                

338,227,902.67

293,372,304.66

 

Total Shareholders' Equity

 

349,227,902.67

 

304,372,304.66

 

Total Liabilities  &  Shareholders'  Equity

 

709,987,316.60

 

568,069,234.62


PROFIT  &  LOSS  ACCOUNT

 

 

Revenue

2005

2004

 

 

 

Sales                                         

1,033,294,862.29

821,380,486.87

Gain  on  Exchange  Rate

862,032.28

-

Gain  from  Sale  of  Assets

245,240.01

408,811.95

Other  Income                 

1,171,365.17

1,112,800.00

 

Total  Revenues           

 

1,035,573,499.75

 

822,902,098.82

 

Expenses

 

 

 

 

 

Cost   of   Goods   Sold                           

520,513,516.88

395,054,753.01

Selling  &  Administrative  Expenses

389,175,751.98

322,146,513.14

Loss  from  Exchange  Rate       

534,044.44

671,909.27

 

Total Expenses             

 

910,223,313.30

 

717,873,175.42

 

 

 

Profit / [Loss]  from  Operation

125,350,186.45

105,028,923.40

Interest  Expenses

[872,567.86]

[1,102,677.04]

Income  Tax

[38,379,319.87]

-

 

Net  Profit / [Loss]

 

86,098,298.72

 

103,926,246.36

 


FINANCIAL  ANALYSIS

 

Annual  Growth  &  Profitability

 

 

Annual  Growth

 

2005

 

2004

 

Net  Sales

 

25.80

 

 

 

Operating  Profit

 

[5.33]

 

 

 

Net  Profit

 

[17.15]

 

 

 

Fixed  Assets

 

20.97

 

 

 

Total  Assets

 

24.98

 

 

 

Profitability

 

 

 

 

 

Cost  of  Good  Sold

 

50.37

 

48.10

 

Operating  Profit  Margin

 

12.18

 

12.87

 

S  &  A  Expenses

 

37.66

 

39.22

 

Interest Paid

 

0.08

 

0.13

 

Other  Revenues

 

0.22

 

0.19

 

Net  Profit  Margin

 

8.33

 

12.65

 

Earning  Per  Shares

 

86.10

 

103.93

 

No. of  Shares

 

1,000,000

 

1,000,000

 

Net  Sales  was  increased  by  25.80%,  Operating  Profit  was  decreased  by  5.33%,  Net  Profit  was  decreased  by  17.15%,  Fixed  Assets  was  increased  by  20.97%,  Total  Assets  was  increased  by  24.98%. 


 

 

Compare  each  cost  with  sales, Cost  of  Good  Sold  was  increased  from  48.10%  to  50.37%,  Operating  Profit  Margin  was  decreased  from  12.87%  to  12.18%,  S  &  A  Expenses  was  decreased  from  39.22%  to  37.66%,  Interest Paid  was  decreased  from  0.13%  to  0.08%,  Other  Revenues  was  increased  from  0.19%  to  0.22%,  Net  Profit  Margin  was  decreased  from  12.65%  to  8.33%. 

 

Earning  Per  Shares  was  decreased  from  103.93  baht  per  share  to  86.10  baht  per  share.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

Liquidity

 

 

Liquidity

 

2005

 

2004

 

Current  Ratio

 

1.46

 

1.56

 

Quick  -  assets  ratio

 

1.06

 

1.05

 

Current  Ratio  was  decreased  from  1.56  to  1.46,  show  Current  Assets  can  cover  Current  Liabilities,  Liquidity  Ratio  of  the  company  was  so  good,  Quick  -  assets  ratio  was  increased  from  1.05  to  1.06,  capacity  to  pay  Short  Term  Loan  was  good  too,  because  Current  Assets  without  Inventory  can  cover  Current  Liabilities.

 

 

 

 

 

 

 

 

 

 

 

 


 

Leverage

 

 

Leverage

 

2005

 

2004

 

D/E  Ratio

 

1.03

 

0.87

 

Times  Interest  Earned

 

144.27

 

95.86

 

D/E  Ratio  was  increased  from  0.87  to  1.03,  show  the  company  had  fund  from  Loan  more  than  fund  from  Equity,  investment  risked  of  the  company  is  medium,  Times  Interest  Earned  was  increased  from  95.86  to  144.27,  capacity  to  pay  interest  paid  was   good.

 

 

 

 

 

 

 

 

 

 

 


Efficiency

 

 

Efficiency

 

2005

 

2004

 

Fixed  Assets  Turnover

 

6.15

 

5.91

 

Total  Assets  Turnover

 

1.46

 

1.45

 

Return  on  Assets

 

12.13

 

18.29

 

Return  on  Equity

 

24.65

 

34.14

 

Day's  Payable

 

52

 

41

 

Day’s  Inventories

 

35

 

44

 

Day’s  Receivables

 

116

 

115

 

Fixed  Assets  Turnover  was  increased  from  5.91  times  to  6.15  times,  Total  Assets  Turnover  was  increased  from  1.45  times  to  1.46  times,  show  the  company  could  use  Assets  so  efficiently,  Return  on  Assets  was  decreased  from  18.29  to  12.13,  Return  on  Equity  was  decreased  from  34.14  to  24.65,  capacity  to  use  Assets  to  make  profit  was  not  good.

 

Day's  Payable  was  increased  from  41  days  to  52  days,  while  Day’s  Inventories  was  decreased  from  44  days  to  35  days,  but  Day’s  Receivables  was  increased  from  115  days  to  116  days.

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions